$5.20
-$0.02
(-0.38%)
Quote as of 4:00 PM EST on 02/08/12
Oncolytics Biotech, Inc. (USA)
NASDAQ:ONCY
|
$5.20
-$0.02
(-0.38%)
|
|
| Today's Open | $5.14 |
|---|---|
| Previous Close | $5.22 |
| Daily Range | $5.03 - $5.21 |
| 52-Week Range | $3.15 - $6.69 |
| Market Cap | $370.15M |
| P/E Ratio | -16.82 |
| Dividend (Yield) | $0.00 (0.0%) |
| Volume | 84,105 |
| Average Daily Volume | 95,130 |
| Current FY EPS | -$0.35 |
ONCY Information
| Description |
|---|
| A development stage company focuses on the discovery and development of oncolytic viruses for the treatment of cancers. |
| Sector |
| Healthcare |
| Industry |
| Biotechnology |
News & Commentary
Onyx Pharmaceuticals' Shares Jumped: What You Need to Know
Cramer's Mad Money - My Most Unpopular Call in the Last Six Years (4/7/11)
4 Biotech Companies With a Two-Year Cash Cushion, Being Snapped Up by the Smart Money
Why Phase 3 Trials Fail: What Investors Need to Know
U.S. Stock Futures Down Slightly After Last Week's Gains
20 Rallying Stocks Being Targeted by Short Sellers
Momentum Trades: 25 Stocks Hitting New Highs on Institutional Buying
Oncolytics Pushes Its Pipeline Further
Amgen, Celgene and Novartis in the Fight Against Pancreatic Cancer
